Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Abstract

<P>La présente invention concerne l'utilisation de l'Efaroxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.</P>

Claims

Description

Topics

    Download Full PDF Version (Non-Commercial Use)

    Patent Citations (2)

      Publication numberPublication dateAssigneeTitle
      EP-0071368-A1February 09, 1983Reckitt And Colman Products LimitedImidazolinderivate
      EP-0486385-A1May 20, 1992Adir Et CompagnieImidazole derivatives, process for their fabrication and pharmaceutical compositions containing them

    NO-Patent Citations (4)

      Title
      ARCH.INT.PHARMACODYN.THER. vol. 277, no. 2 , 1985 pages 180 - 191 G.JOLY ET AL. 'Antagonistic Effects of S9871 or (imidazolinyl-2)-2-dihydro 2,3 benzofurane and its Stereoisomers on Some Central and Peripheral Actions of alpha2-Agonists'
      BRAIN RES. vol. 562, no. 2 , 25 Octobre 1991 pages 216 - 224 M.MAVRIDIS ET AL. 'Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha1 as compared to alpha2 agonists and antagonists'
      J.MED.CHEM. vol. 27, no. 5 , 1984 pages 570 - 576 C.B.CHAPLEO ET AL. 'Alpha-Adrenoreceptor Reagents. 2. Effects of Modification of the 1,4-Benzodioxan Ring System on alpha-Adrenoreceptor Activity'
      NEUROLOGY vol. 41, no. 7 , Juillet 1991 pages 986 - 991 J.GHIKA ET AL. 'Idazoxan treatment in progressive supranuclear palsy'

    Cited By (0)

      Publication numberPublication dateAssigneeTitle